{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:PDE4",
      "entity_text" : "PDE4",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02057",
      "entity_text" : "AN2728",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "AN2728 which inhibits PDE4 has been administered topically in phase 2 studies to patients with psoriasis or AD [XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-08-04T13:31:14Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T13:25:03Z",
  "trigger" : "inhibits",
  "evidence" : [ "AN2728 which inhibits PDE4" ],
  "pmc_id" : "3680635",
  "score" : 0
}